{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:02:38Z","timestamp":1781881358350,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.biopha.2026.119054","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T04:41:12Z","timestamp":1769748072000},"page":"119054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The calcimimetic etelcalcetide attenuates pressure overload\u2013induced cardiac hypertrophy in rats with and without chronic kidney disease"],"prefix":"10.1016","volume":"196","author":[{"given":"Hidehisa","family":"Okamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9968-9896","authenticated-orcid":false,"given":"Yuma","family":"Nose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6878-9965","authenticated-orcid":false,"given":"Hayaki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7610-1068","authenticated-orcid":false,"given":"Hideki","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9889","key":"10.1016\/j.biopha.2026.119054_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.biopha.2026.119054_bib2","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1681\/ASN.2004070597","article-title":"Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease","volume":"16","author":"Weiner","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"22","key":"10.1016\/j.biopha.2026.119054_bib3","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.biopha.2026.119054_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41371-022-00751-4","article-title":"Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations","volume":"37","author":"Law","year":"2023","journal-title":"J. Hum. Hypertens."},{"issue":"2","key":"10.1016\/j.biopha.2026.119054_bib5","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.ajkd.2005.04.031","article-title":"Left ventricular hypertrophy in nondiabetic predialysis CKD","volume":"46","author":"Paoletti","year":"2005","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.biopha.2026.119054_bib6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ki.1989.192","article-title":"Impact of left ventricular hypertrophy on survival in end-stage renal disease","volume":"36","author":"Silberberg","year":"1989","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.biopha.2026.119054_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5301\/JN.2010.2030","article-title":"Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review","volume":"24","author":"Cerasola","year":"2011","journal-title":"J. Nephrol."},{"key":"10.1016\/j.biopha.2026.119054_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bone.2016.11.012","article-title":"Vascular calcification in CKD-MBD: roles for phosphate, FGF23, and Klotho","volume":"100","author":"Yamada","year":"2017","journal-title":"Bone"},{"issue":"22","key":"10.1016\/j.biopha.2026.119054_bib9","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.ehj.2003.09.010","article-title":"R. Parathyroid hormone and left ventricular hypertrophy","volume":"24","author":"Schirmer","year":"2003","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.biopha.2026.119054_bib10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.nefro.2021.02.001","article-title":"Contribution of phosphorus and PTH to the development of cardiac hypertrophy and fibrosis in an experimental model of chronic renal failure","volume":"41","author":"Mart\u00ednez-Arias","year":"2021","journal-title":"Nefrol. (Engl. Ed. )"},{"issue":"1","key":"10.1016\/j.biopha.2026.119054_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1081\/JDI-100001291","article-title":"Parathormon, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients","volume":"23","author":"Str\u00f3zecki","year":"2001","journal-title":"Ren. Fail"},{"issue":"19","key":"10.1016\/j.biopha.2026.119054_bib12","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Guti\u00e9rrez","year":"2009","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.biopha.2026.119054_bib13","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J. Clin. Invest"},{"issue":"10","key":"10.1016\/j.biopha.2026.119054_bib14","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1681\/ASN.2014060543","article-title":"Klotho protects against indoxyl sulphate-induced myocardial hypertrophy","volume":"26","author":"Yang","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119054_bib15","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1681\/ASN.V12122759","article-title":"Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study","volume":"12","author":"London","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119054_bib16","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2353\/ajpath.2010.091292","article-title":"Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats","volume":"177","author":"Kong","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"43","key":"10.1016\/j.biopha.2026.119054_bib17","doi-asserted-by":"crossref","first-page":"16810","DOI":"10.1073\/pnas.0611202104","article-title":"Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals","volume":"104","author":"Bodyak","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2026.119054_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0272-6386(99)70260-X","article-title":"Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism","volume":"33","author":"Park","year":"1999","journal-title":"Am. J. Kidney Dis."},{"issue":"7","key":"10.1016\/j.biopha.2026.119054_bib19","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial","volume":"307","author":"Thadhani","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.biopha.2026.119054_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2013010103","article-title":"Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial","volume":"25","author":"Wang","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119054_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.114.013876","article-title":"Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: the evaluation of cinacalcet hcl therapy to lower cardiovascular events (EVOLVE) trial","volume":"132","author":"Moe","year":"2015","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.biopha.2026.119054_bib22","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/CIRCRESAHA.120.318556","article-title":"Randomized trial of etelcalcetide for cardiac hypertrophy in hemodialysis","volume":"128","author":"D\u00f6rr","year":"2021","journal-title":"Circ. Res"},{"issue":"10","key":"10.1016\/j.biopha.2026.119054_bib23","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1177\/1535370219854325","article-title":"Calcimimetic R568 improved cardiac remodeling by classic and novel renin-angiotensin system in spontaneously hypertensive rats","volume":"244","author":"Zhang","year":"2019","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"26","key":"10.1016\/j.biopha.2026.119054_bib24","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Chertow","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.biopha.2026.119054_bib25","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1111\/bph.12955","article-title":"Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP","volume":"172","author":"McGrath","year":"2015","journal-title":"Br. J. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2026.119054_bib26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2016.19468","article-title":"Effect of etelcalcetide vs cinacalcet on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: a randomized clinical trial","volume":"317","author":"Block","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.biopha.2026.119054_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12902","article-title":"PTH, vitamin D, and the FGF-23-klotho axis and heart: Going beyond the confines of nephrology","volume":"48","author":"Navarro-Garc\u00eda","year":"2018","journal-title":"Eur. J. Clin. Invest"},{"issue":"1","key":"10.1016\/j.biopha.2026.119054_bib28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3858\/emm.2010.42.1.006","article-title":"Parathyroid hormone accelerates decompensation following left ventricular hypertrophy","volume":"42","author":"Cha","year":"2010","journal-title":"Exp. Mol. Med"},{"issue":"6","key":"10.1016\/j.biopha.2026.119054_bib29","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.biopha.2026.119054_bib30","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbrc.2018.02.098","article-title":"Activation of calcium-sensing receptor-mediated autophagy in angiotensinII-induced cardiac fibrosis in vitro","volume":"497","author":"Chi","year":"2018","journal-title":"Biochem Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119054_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3892\/mmr.2016.5279","article-title":"Suppression of calcium\u2011sensing receptor ameliorates cardiac hypertrophy through inhibition of autophagy","volume":"14","author":"Liu","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2026.119054_bib32","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jgr.2021.03.006","article-title":"Ginsenoside Rg1 attenuates mechanical stress-induced cardiac injury via calcium sensing receptor-related pathway","volume":"45","author":"Lu","year":"2021","journal-title":"J. Ginseng Res."},{"issue":"8","key":"10.1016\/j.biopha.2026.119054_bib33","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/00004872-200108000-00007","article-title":"Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats","volume":"19","author":"Paull","year":"2001","journal-title":"J. Hypertens."},{"issue":"2","key":"10.1016\/j.biopha.2026.119054_bib34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","article-title":"A calcineurin-dependent transcriptional pathway for cardiac hypertrophy","volume":"93","author":"Molkentin","year":"1998","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.biopha.2026.119054_bib35","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bbrc.2008.02.053","article-title":"Involvement of calcium-sensing receptor in cardiac hypertrophy-induced by angiotensinII through calcineurin pathway in cultured neonatal rat cardiomyocytes","volume":"369","author":"Wang","year":"2008","journal-title":"Biochem Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2026.119054_bib36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ceca.2011.11.009","article-title":"Biased agonism of the calcium-sensing receptor","volume":"51","author":"Thomsen","year":"2012","journal-title":"Cell Calcium"},{"issue":"1","key":"10.1016\/j.biopha.2026.119054_bib37","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/s41598-018-19327-9","article-title":"Activation of Ca2+-sensing receptor as a protective pathway to reduce Cadmium-induced cytotoxicity in renal proximal tubular cells","volume":"8","author":"Gu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119054_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1874216501105010001","article-title":"The Calcium-Sensing Receptor is Upregulated in Post Myocardial Infarct Hearts and Downregulates ANP Expression in Rat Cardiac Myocytes but is Not Expressed in Rat Cardiac Fibroblasts In Vitro","volume":"5","author":"Jabbari","year":"2011","journal-title":"Open Endocrinol. J."},{"issue":"11","key":"10.1016\/j.biopha.2026.119054_bib39","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1681\/ASN.V8111764","article-title":"Relationship between left ventricular hypertrophy and plasma renin activity in chronic hemodialysis patients","volume":"8","author":"Vlahakos","year":"1997","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119054_bib40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11906-009-0030-9","article-title":"Left ventricular hypertrophy and renin-angiotensin system blockade","volume":"11","author":"Cowan","year":"2009","journal-title":"Curr. Hypertens. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2026.119054_bib41","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/HYPERTENSIONAHA.109.136655","article-title":"Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies","volume":"54","author":"Fagard","year":"2009","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.biopha.2026.119054_bib42","first-page":"4089","article-title":"Calcimimetic R568 reduced the blood pressure and improved aortic remodeling in spontaneously hypertensive rats by inhibiting local renin-angiotensin system activity","volume":"16","author":"Sun","year":"2018","journal-title":"Exp. Ther. Med"},{"issue":"4","key":"10.1016\/j.biopha.2026.119054_bib43","doi-asserted-by":"crossref","first-page":"R1020","DOI":"10.1152\/ajpregu.00238.2010","article-title":"Acute activation of the calcium-sensing receptor inhibits plasma renin activity in vivo","volume":"299","author":"Atchison","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119054_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044161","article-title":"A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model","volume":"7","author":"Dai","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2026.119054_bib45","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fendo.2020.00539","article-title":"The interplay between the renin-angiotensin-aldosterone system and parathyroid hormone","volume":"11","author":"Zheng","year":"2020","journal-title":"Front. Endocrinol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119054_bib46","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10157-018-1680-1","article-title":"Changes in serum and intracardiac fibroblast growth factor 23 during the progression of left ventricular hypertrophy in hypertensive model rats","volume":"23","author":"Fujii","year":"2019","journal-title":"Clin. Exp. Nephrol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119054_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10140-4","article-title":"Genetic Ablation of Fgf23 or Klotho Does not Modulate Experimental Heart Hypertrophy Induced by Pressure Overload","volume":"7","author":"Slavic","year":"2017","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2026.119054_bib48","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/ndt\/gfy006","article-title":"Fibroblast growth factor 23 is induced by an activated renin-angiotensin-aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts","volume":"33","author":"Leifheit-Nestler","year":"2018","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.biopha.2026.119054_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1276664","article-title":"Exploring the implications of blocking renin-angiotensin-aldosterone system and fibroblast growth factor 23 in early left ventricular hypertrophy without chronic kidney disease","volume":"14","author":"Watanabe","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119054_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10060931","article-title":"Oxidative stress as a mechanism for functional alterations in cardiac hypertrophy and heart failure","volume":"10","author":"Shah","year":"2021","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.biopha.2026.119054_bib51","article-title":"Non-additive effects of combined nox1\/4 inhibition and calcimimetic treatment on a rat model of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"6","author":"Damrath","year":"2022","journal-title":"JBMR"},{"issue":"9","key":"10.1016\/j.biopha.2026.119054_bib52","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s11255-014-0723-0","article-title":"Cinacalcet may improve oxidative DNA damage in maintenance hemodialysis patients: an observational study","volume":"46","author":"Ari","year":"2014","journal-title":"Int Urol. Nephrol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:46:21Z","timestamp":1781880381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226000867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":52,"alternative-id":["S0753332226000867"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119054","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The calcimimetic etelcalcetide attenuates pressure overload\u2013induced cardiac hypertrophy in rats with and without chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119054"}}